Company: Oncolytics Biotech Inc. Symbol: TSX: ONC, OTCQX: ONCYF Length: 00:23:53 Presenter: Dr. Brad Thompson, Chairman, President & CEO Occasion: Richmond Club Lunch, Toronto Oncolytics Biotech Inc. is focused on the development of oncolytic viruses for use as cancer therapeutics. The Company’s lead product, REOLYSIN®, a proprietary formulation of the human reovirus, is currently in …

Oncolytics Biotech Focused on Oncolytic Viruses for Cancer Therapeutics Read More »